Response to “Why the Nipple is an Unreliable Marker for Measuring Breast Ptosis”
Ben M. Eyck(Erasmus MC Cancer Institute), Hieronymus P. Stevens(Plastic Surgery Hospital), Joris A. van Dongen(Erasmus University Rotterdam), João Martins(University of Groningen), Thanassi Athanassopoulos(University of Groningen)
Cited by 0
Related Papers
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial
|The Lancet Oncology|2025|95
Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
|Annals of Surgery|2019|88